Waverley Pharma Inc. announced the appointment, by the board of directors, of Mr. Larry Thiessen as the new President and Chief Executive Officer, effective February 1, 2020. Mr. Thiessen has extensive pharmaceutical experience having worked for Bausch Health Companies Inc., for the past 28 years, working his way up from manager to site director of the manufacturing operation in Steinbach, Manitoba. He led a team of roughly 400 employees and provided overall leadership and strategic direction at the operation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% | 0.00% | -40.00% |
Jun. 20 | Waverley Pharma Inc. Elects James Kinley as Director | CI |
May. 29 | Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 595K | |
+20.95% | 127B | |
+23.00% | 117B | |
+26.70% | 27.77B | |
-19.75% | 20.44B | |
-14.87% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- WAVE Stock
- News Waverley Pharma Inc.
- Waverley Pharma Inc. Announces Appoint of Larry Thiessen as the New President and Chief Executive Officer